Article thumbnail

Is a deep response the key to successful treatment of multiple myeloma?

By J. Liwing, B.M. Heeg, S. Karstorp, M. Postma, R. Silvennoinen, M. Putkonen, P. Anttila, K. Remes, N. Abildgaard, A. Waage and H. Nahi
Topics: albumin, creatine, beta 2 microglobulin, calcium, multiple myeloma, European, hematology, human, patient, proportional hazards model, Finland, response time, Denmark, therapy, hospital, independent variable, male, gender, overall survival, hazard ratio, data base, Sweden, Norway, treatment response, chemotherapy
Year: 2015
OAI identifier: oai:pure.rug.nl:publications/8766f9b1-86d4-4a3e-95cf-f215db3b0733
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://www.rug.nl/research/po... (external link)
  • http://hdl.handle.net/11370/87... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles